A radical approach synthesizes C-glycoside molecules, highlighting potential in diabetes drug development.
A platform for synthesizing highly desirable C-glycoside molecules from sugar has been developed that uses glycosyl sulfonyl hydrazides as readily accessible free-radical precursors. The strategy enables targeted formation of carbon–carbon bonds across carbohydrate scaffolds and with specificity for the desired 3D arrangement of atoms. A class of diabetes drug could be easier to make using this synthetic route.
No takes yet. Share an insight, caveat, or question.
A 2026 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: